Opto Circuits is working towards improving its footprint in the domestic market by participating in the Make in India initiative, says CMD Vinod Ramnani in an interview to CNBC-TV18.
The move is to consolidate all subsidiaries of the company in order to focus on the core business, says Vinod Ramani, CMD of Opto Circuits.
Vinod Ramnani, CMD, Opto Circuits told CNBC-TV18 that the new catheter would help them gain market share because as of now, only 2-3 companies make this product. So, there is huge opportunity for this.
Vinod Ramnani, Chairman and Managing Director, Opto Circuits, discusses about the company's future outlook.
Opto Circuits group company Cardiac Science has introduced automated external Defibrillator (AED) Powerheart G5 in US and Canadian markets, said Vinod Ramnani, CMD, Opto Circuits.
V Bhaskar of Opto Circuits Group said the company was not looking for any FDI as of now.
Speaking about its fourth quarter numbers, Vinod Ramnani of Opto Circuits said it was below expectations and the company is taking steps to address working capital issues.
Opto Circuit's group company, Cardiac Science Corporation, has got some new orders and will begin supply of the same by the end of January. In an interview to CNBC-TV18, V Bhaskar, Director of Opto Circuits shares details.
Opto Circuits signed a pack with a Japanese company Omron for distribution of automated external defibrillator (AED). V Bhaskar, director-finance at Opto Circuits, in an interview with CNBC-TV18’s Gautam Broker and Latha Venkatesh, said that each of the unit would cost around USD 10-12 million for the period of operations.